Evaxion A (EVAX) Other Non Operating Income (2020 - 2025)
Evaxion A posted quarterly Other Non Operating Income of -$45000.0 for Q2 2025, down 287.5% year-on-year from $24000.0 in Q2 2024, and down 287.5% on a QoQ basis from $24000.0 in Q2 2024.
Evaxion A (EVAX) has 6 years of Other Non Operating Income data on file, last reported at -$45000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -45,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Sep 30, 2021 | -32,000.00 |
| Jun 30, 2021 | -57,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | -10,000.00 |